[go: up one dir, main page]

MX2008001541A - Metodos para la preparacion de inhibidores de polimerasa del vhc. - Google Patents

Metodos para la preparacion de inhibidores de polimerasa del vhc.

Info

Publication number
MX2008001541A
MX2008001541A MX2008001541A MX2008001541A MX2008001541A MX 2008001541 A MX2008001541 A MX 2008001541A MX 2008001541 A MX2008001541 A MX 2008001541A MX 2008001541 A MX2008001541 A MX 2008001541A MX 2008001541 A MX2008001541 A MX 2008001541A
Authority
MX
Mexico
Prior art keywords
preparation
methods
hcv polymerase
polymerase inhibitors
inhibitors
Prior art date
Application number
MX2008001541A
Other languages
English (en)
Inventor
Christopher Frederick Matthews
Robert William Scott
John Lloyd Tucker
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX2008001541A publication Critical patent/MX2008001541A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

La presente invencion se refiere a metodos y compuestos utiles en la preparacion de compuestos de la formula: (ver formula (I)).
MX2008001541A 2005-08-24 2006-08-16 Metodos para la preparacion de inhibidores de polimerasa del vhc. MX2008001541A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US71104205P 2005-08-24 2005-08-24
US74427306P 2006-04-04 2006-04-04
US80464406P 2006-06-13 2006-06-13
PCT/IB2006/002342 WO2007023381A1 (en) 2005-08-24 2006-08-16 Methods for the preparation of hcv polymerase inhibitors

Publications (1)

Publication Number Publication Date
MX2008001541A true MX2008001541A (es) 2008-02-15

Family

ID=37198917

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008001541A MX2008001541A (es) 2005-08-24 2006-08-16 Metodos para la preparacion de inhibidores de polimerasa del vhc.

Country Status (14)

Country Link
US (2) US7807838B2 (es)
EP (1) EP1928878A1 (es)
JP (1) JP2007056022A (es)
KR (1) KR101064459B1 (es)
CN (1) CN102336758A (es)
AR (1) AR059114A1 (es)
AU (1) AU2006283297B2 (es)
BR (1) BRPI0615016A2 (es)
CA (1) CA2619077C (es)
IL (1) IL189210A0 (es)
MX (1) MX2008001541A (es)
NZ (1) NZ565496A (es)
TW (2) TWI316516B (es)
WO (1) WO2007023381A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010526143A (ja) 2007-05-04 2010-07-29 バーテックス ファーマシューティカルズ インコーポレイテッド Ｈｃｖ感染の処置のための併用療法
MX2010001650A (es) * 2007-08-10 2010-08-02 Glaxosmithkline Llc Entidades quimicas biciclicas que contienen nitrogeno para el tratamiento de infecciones virales.
US8717565B2 (en) * 2008-12-17 2014-05-06 The Lubrizol Corporation Optically active functional fluid markers
WO2011127933A1 (en) 2010-04-16 2011-10-20 Nuevolution A/S Bi-functional complexes and methods for making and using such complexes
WO2016205678A1 (en) * 2015-06-19 2016-12-22 Emory University Methods of measuring cell purity for making quality control determinations and related compositions
BR112018072042A2 (pt) * 2016-05-31 2019-03-12 Hoffmann La Roche métodos de detecção de polipeptídeo e de processamento prévio de amostras, reagente de processamento prévio, kit de detecção de hcv e uso de composição
CN107744831B (zh) * 2017-08-31 2020-04-21 博事利达（苏州）生物科技有限公司 一类奎尼定衍生物催化剂、制备方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US176701A (en) * 1876-04-25 Improvement in school-furniture
RU2223958C2 (ru) * 1997-09-11 2004-02-20 Фармация Энд Апджон Компани Новый способ получения ингибитора протеазы
EP2335700A1 (en) * 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
DOP2003000641A (es) * 2002-05-10 2003-11-15 Pfizer Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan
US7148226B2 (en) * 2003-02-21 2006-12-12 Agouron Pharmaceuticals, Inc. Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
PL1781662T3 (pl) * 2004-08-18 2011-08-31 Pfizer Inhibitory zależnej od RNA polimerazy RNA wirusa zapalenia wątroby typu C, i kompozycje i terapie wykorzystujące je

Also Published As

Publication number Publication date
IL189210A0 (en) 2008-06-05
CA2619077A1 (en) 2007-03-01
US20090023921A1 (en) 2009-01-22
TW200942546A (en) 2009-10-16
WO2007023381A1 (en) 2007-03-01
CA2619077C (en) 2011-09-13
NZ565496A (en) 2010-10-29
TW200740817A (en) 2007-11-01
JP2007056022A (ja) 2007-03-08
EP1928878A1 (en) 2008-06-11
KR20080038354A (ko) 2008-05-06
KR101064459B1 (ko) 2011-09-16
AU2006283297B2 (en) 2012-07-26
TWI316516B (en) 2009-11-01
BRPI0615016A2 (pt) 2011-05-03
AU2006283297A1 (en) 2007-03-01
TWI320412B (en) 2010-02-11
CN102336758A (zh) 2012-02-01
US20110070187A1 (en) 2011-03-24
AR059114A1 (es) 2008-03-12
US7807838B2 (en) 2010-10-05

Similar Documents

Publication Publication Date Title
IL198741A0 (en) Hepatitis c virus inhibitor compounds, compositions containing the same and uses thereof
MX2009004888A (es) Inhibidores del virus de la hepatitis c.
TW200716133A (en) Anti-infective agents
MX2009004556A (es) Inhibidores de la proteasa ns3 del hcv.
WO2008008776A3 (en) Hepatitis c virus inhibitors
NO20075616L (no) Tripeptider som hepatitt C virus inhibitorer
MX2007008137A (es) Triazoloftalazinas como inhibidores de pde2.
TN2010000044A1 (en) Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
MX2010002904A (es) N-fenil-dioxo-hidropirimidinas utiles como inhibidores de virus de hepatitis c (hcv).
ZA200701137B (en) Triazolophthalazines
TNSN08033A1 (en) Hcv ns3 protease inhibitors
MX2010006738A (es) Inhibidores de proteasa del virus de la hepatitis c (hcv) y usos de los mismos.
MX2010006736A (es) Inhibidores de proteasa del virus de la hepatitis c (hcv) y usos de los mismos.
UA91255C2 (uk) Антивірусні нуклеозиди
MX2011009644A (es) Inhibidores del virus de la hepatitis c.
PL1987038T3 (pl) Inhibitory HCV NS5B
NO20080129L (no) Fremgangsmate for fremstilling av dihydrokinazoliner
MX2011006631A (es) Inhibidores de proteasa ns3 del virus hcv.
UA83875C2 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов
TW200624426A (en) BACE inhibitors
TW200621721A (en) Methods of preparing indazole compounds
SG158091A1 (en) Imidazoazepinone compounds
WO2006072612A3 (en) Triazolophthalazines as pde2- inhibitors
TW200613308A (en) Cyclobutanetetracarboxylate compound and preparation method thereof
IL189210A0 (en) Methods for the preparation of hcv polymerase inhibitors

Legal Events

Date Code Title Description
FG Grant or registration